STOCK TITAN

iHuman Inc. Files 2024 Annual Report on Form 20-F

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

iHuman, a leading Chinese provider of tech-powered intellectual development products, has filed its annual report on Form 20-F for the fiscal year 2024 with the U.S. Securities and Exchange Commission.

Key points from the announcement:

  • Filing Date: April 28, 2025
  • Report Type: Annual Report (Form 20-F)
  • Fiscal Period: Year ended December 31, 2024
  • Availability: Accessible on company's investor relations website at ir.ihuman.com
  • Shareholder Service: Free hard copies available upon request

The company has confirmed it will provide complimentary hard copies of the annual report, including complete audited financial statements, to shareholders and ADS holders who request them. Interested parties can direct their requests to the company's headquarters in Beijing's Chaoyang District.

Loading...
Loading translation...

Positive

  • Timely filing of annual report with SEC, demonstrating regulatory compliance
  • Transparent shareholder communication with free hard copy reports available upon request

Negative

  • None.

News Market Reaction 1 Alert

+0.97% News Effect

On the day this news was published, IH gained 0.97%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

BEIJING, April 28, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it filed its annual report on Form 20-F for the year ended December 31, 2024 with the U.S. Securities and Exchange Commission on April 28, 2025. The annual report on Form 20-F is available on the Company's investor relations website at https://ir.ihuman.com/. iHuman will provide a hard copy of its annual report on Form 20-F containing complete audited financial statements for the year ended December 31, 2024, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to iHuman Inc., Building A, No. 1 Wangjing East Road, Chaoyang District, Beijing 100012, People's Republic of China.

About iHuman Inc.

iHuman Inc. is a leading provider of tech-powered, intellectual development products in China that is committed to making the child-upbringing experience easier for parents and transforming intellectual development into a fun journey for children. Benefiting from a deep legacy that combines over two decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman's unique, fun and interactive product offerings stimulate children's natural curiosity and exploration. The Company's comprehensive suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety of areas to develop children's abilities in speaking, critical thinking, independent reading and creativity, and foster their natural interest in traditional Chinese culture. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and big data analysis on children's behavior & psychology, iHuman believes it will continue to provide superior experience that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated suite of tech-powered, intellectual development products.

For more information about iHuman, please visit https://ir.ihuman.com/.

For investor and media enquiries, please contact:

iHuman Inc.
Mr. Justin Zhang
Investor Relations Director
Phone: +86-10-5780-6606
E-mail: ir@ihuman.com

Christensen
In China
Ms. Alice Li
Phone: +86-10-5900-1548
E-mail: alice.li@christensencomms.com

In the US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
E-mail: linda.bergkamp@christensencomms.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ihuman-inc-files-2024-annual-report-on-form-20-f-302440209.html

SOURCE iHuman Inc.

FAQ

When did iHuman (NYSE: IH) file its 2024 annual report?

iHuman (NYSE: IH) filed its 2024 annual report on Form 20-F with the SEC on April 28, 2025.

How can shareholders get a copy of iHuman's (IH) 2024 annual report?

Shareholders can access the report online at ir.ihuman.com or request a free hard copy by contacting iHuman's Beijing office at Building A, No. 1 Wangjing East Road.

What period does iHuman's (IH) latest Form 20-F cover?

The Form 20-F covers iHuman's financial performance for the year ended December 31, 2024.

Where can investors find iHuman's (IH) 2024 financial statements?

Complete audited financial statements for 2024 are available in iHuman's Form 20-F on their investor relations website at ir.ihuman.com.

What type of regulatory filing did iHuman (IH) submit to the SEC in April 2025?

iHuman submitted its annual report on Form 20-F, which is a required SEC filing for foreign companies listed on U.S. exchanges.
Ihuman Inc

NYSE:IH

IH Rankings

IH Latest News

IH Latest SEC Filings

IH Stock Data

110.88M
22.54M
0.79%
Education & Training Services
Consumer Defensive
Link
China
Beijing